126 related articles for article (PubMed ID: 35914860)
41. Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.
Azimi A; Majidinia M; Shafiei-Irannejad V; Jahanban-Esfahlan R; Ahmadi Y; Karimian A; Mir SM; Karami H; Yousefi B
Gene; 2018 Feb; 642():249-255. PubMed ID: 29126924
[TBL] [Abstract][Full Text] [Related]
42. Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt.
Deng LJ; Hu LP; Peng QL; Yang XL; Bai LL; Yiu A; Li Y; Tian HY; Ye WC; Zhang DM
Chem Biol Interact; 2014 Aug; 219():184-94. PubMed ID: 24954031
[TBL] [Abstract][Full Text] [Related]
43. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells.
Liu W; Ning R; Chen RN; Huang XF; Dai QS; Hu JH; Wang YW; Wu LL; Xiong J; Hu G; Guo QL; Yang J; Wang H
Mol Carcinog; 2016 May; 55(5):440-57. PubMed ID: 25683703
[TBL] [Abstract][Full Text] [Related]
44. Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2.
Luo Y; Wen X; Wang L; Gao J; Wang Z; Zhang C; Zhang P; Lu C; Duan L; Tian Y
Oxid Med Cell Longev; 2016; 2016():7530853. PubMed ID: 27597883
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms.
Feng CP; Tang HM; Huang S; Hou SZ; Liang J; Huang W; Lai XP
J Ethnopharmacol; 2016 Jul; 188():70-9. PubMed ID: 27132715
[TBL] [Abstract][Full Text] [Related]
46. Polychlorinated Biphenyl Quinone Metabolite Promotes p53-Dependent DNA Damage Checkpoint Activation, S-Phase Cycle Arrest and Extrinsic Apoptosis in Human Liver Hepatocellular Carcinoma HepG2 Cells.
Song X; Li L; Shi Q; Lehmler HJ; Fu J; Su C; Xia X; Song E; Song Y
Chem Res Toxicol; 2015 Nov; 28(11):2160-9. PubMed ID: 26451628
[TBL] [Abstract][Full Text] [Related]
47. Up and down-regulation of mRNA in the cytotoxicity and genotoxicity of Plumbagin in HepG2/C3A.
Vaz Crippa G; Zanetti TA; Biazi BI; Baranoski A; Marques LA; Coatti GC; Lepri SR; Mantovani MS
Environ Toxicol Pharmacol; 2020 Apr; 75():103328. PubMed ID: 32000057
[TBL] [Abstract][Full Text] [Related]
48. PUMA and survivin are involved in the apoptosis of HepG2 cells induced by microcystin-LR via mitochondria-mediated pathway.
Ma J; Feng Y; Liu Y; Li X
Chemosphere; 2016 Aug; 157():241-9. PubMed ID: 27235693
[TBL] [Abstract][Full Text] [Related]
49. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
50. Single high dose irradiation induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cells through the Ras/Raf/MEK/ERK pathways.
Tian X; Geng J; Zheng Q; Wang L; Huang P; Tong J; Zheng S
Int J Radiat Biol; 2020 Jun; 96(6):740-747. PubMed ID: 32039644
[No Abstract] [Full Text] [Related]
51. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
Gao C; Li X; Yu S; Liang L
J BUON; 2019; 24(5):1964-1969. PubMed ID: 31786862
[TBL] [Abstract][Full Text] [Related]
52. Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing.
Štampar M; Tomc J; Filipič M; Žegura B
Arch Toxicol; 2019 Nov; 93(11):3321-3333. PubMed ID: 31542801
[TBL] [Abstract][Full Text] [Related]
53. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
54. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
[TBL] [Abstract][Full Text] [Related]
55. Cytotoxicity, genotoxicity, oxidative stress, and apoptosis in HepG2 cells induced by the imidazole ionic liquid 1-dodecyl-3-methylimidazolium chloride.
Wang P; Wan R; Huo W; Dong H; Chang Z; Xia X
Environ Toxicol; 2020 Jun; 35(6):665-672. PubMed ID: 31916396
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of heat shock protein 70 and the differential protein expression induced by tumor necrosis factor-alpha enhances migration and inhibits apoptosis of hepatocellular carcinoma cell HepG2.
Huang BP; Lin CS; Wang CJ; Kao SH
Int J Med Sci; 2017; 14(3):284-293. PubMed ID: 28367089
[TBL] [Abstract][Full Text] [Related]
57. A sub-chronic Xysmalobium undulatum hepatotoxicity investigation in HepG2/C3A spheroid cultures compared to an in vivo model.
Calitz C; Hamman JH; Fey SJ; Viljoen AM; Gouws C; Wrzesinski K
J Ethnopharmacol; 2019 Jul; 239():111897. PubMed ID: 31009705
[TBL] [Abstract][Full Text] [Related]
58. The antitumor effect of formosanin C on HepG2 cell as revealed by 1H-NMR based metabolic profiling.
Li Y; Man S; Li J; Chai H; Fan W; Liu Z; Gao W
Chem Biol Interact; 2014 Sep; 220():193-9. PubMed ID: 25014414
[TBL] [Abstract][Full Text] [Related]
59. Transcriptome analysis of signaling pathways targeted by Ellagic acid in hepatocellular carcinoma cells.
Qiu S; Zhong C; Zhao B; Li G; Wang J; Jehan S; Li J; Zhao X; Li D; Sui G
Biochim Biophys Acta Gen Subj; 2021 Jul; 1865(7):129911. PubMed ID: 33862123
[TBL] [Abstract][Full Text] [Related]
60. Salinomycin induces cell cycle arrest and apoptosis and modulates hepatic cytochrome P450 mRNA expression in HepG2/C3a cells.
Niwa AM; Semprebon SC; D'Epiro GFR; Marques LA; Zanetti TA; Mantovani MS
Toxicol Mech Methods; 2022 Jun; 32(5):341-351. PubMed ID: 34806536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
